Safety and Immunogenicity of Fluzone Quadrivalent Vaccine Administered to Healthy Children 6 Months to < 36 Months of Age

Trial Profile

Safety and Immunogenicity of Fluzone Quadrivalent Vaccine Administered to Healthy Children 6 Months to < 36 Months of Age

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 30 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top